Fundraising Fox
🦊/People
Sign in

James Hardiman

Investor

General Partner at DCVC (Data Collective) · Board director at Noetik · Board director at Shennon Biotechnologies

San Francisco, California

Writes $5M – $25M checks · typically $15M

Find your path to James

68 people in our graph share verified history with James — schools, employers, funds. One of them is your warm intro.

Dylan ReidunlockedJames: together at Noetik (2022–2026)
James: together at Lumafield
×9James: together at DCVC (Data Collective)
James: together at Noetik

About

Has invested at DCVC since 2013, focusing on technologies that characterize, model, or manipulate biological systems, robotics and automation, vertical AI applications, and frontier tech like quantum computing. Previously worked on data-driven sales and marketing strategy for life-science and healthcare companies, with experience in healthcare data analysis, materials R&D, and semiconductor processing.

Contact· self-published, not guessed

Likely email· guessed from name + firm domain, not firm-published

Invests in

AI & Machine LearningBiotechQuantum ComputingRobotics

Beyond investing

Education
Studied at UC Berkeley (Bachelor's, Engineering Physics) Studied at University of Chicago Booth School of Business (MBA)

From published sources — common ground for a warm intro.

Board director at Noetik

Intro paths

→

In turn, James can intro founders to Noetik's investors below.

Noetik's investors · 12

11.2 CapitalLas Vegas · $500K – $3M checks · since 2023Breakout LabsBreakout VenturesSan Francisco · $500K – $6M checksCatalio Capital ManagementNew York · since 2023Catalio Capital Management, LPNew YorkDCVC (Data Collective)Palo Alto · $5M – $25M checks · since 2022EPIC VENTURESSalt Lake City · since 2023Linearis VenturesQuebec CityNorth South VenturesToronto · since 2023Polaris PartnersBoston · $500K – $5M checks · since 2024Wittington VenturesTorontoZetta Venture PartnersSan Francisco · $1M – $5M checks · since 2023

Co-founders at Noetik

JR
Jacob RinaldiExecutive Officer, Director, Promoter
RA
Ronald AlfaExecutive Officer, Director, Promoter
RARon Alfa, MD, PhD
Ron Alfa, MD, PhDFounder

Board director at Shennon Biotechnologies

Intro paths

→

In turn, James can intro founders to Shennon Biotechnologies's investors below.

Shennon Biotechnologies's investors · 6

AV8 VenturesPalo Alto · $500K – $10M checks · since 2022DCVC (Data Collective)Palo Alto · $5M – $25M checks · since 2023Foundation CapitalSan Francisco · $250K – $15M checks · since 2022Future VenturesLos Altos · $1M – $10M checks · since 2022NextGen Venture PartnersSan Francisco · $500K – $2M checks · since 2022Samos InvestmentsLondon · since 2022

Co-founders at Shennon Biotechnologies

LSLi Sun, PhD
Li Sun, PhDFounder/CEO

Experience

  1. Data CollectiveGeneral Partnercurrent2013 — presentSan Francisco Bay Area
  2. Recursion PharmaceuticalsInvestor and Board Observercurrent2017 — present
  3. LumafieldInvestor and Board Directorcurrent2020 — present
  4. Valar LabsInvestor and Board Directorcurrent2023 — present
  5. NOETIKInvestor and Board Directorcurrent2022 — presentUnited States

Skills & more

Strategy7Start-ups

From James's professional profile.

Deals · 1

NoetikBoard seat

via DCVC (Data Collective) · filed Sep 2022 · $8M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Sources: SEC Form D filings · curated public sources.

Colleagues at DCVC (Data Collective)

Alan Cohen
General Partner at DCVC (Data Collective)
Ali Tamaseb
General Partner at DCVC (Data Collective)
Allyson Kaufman
Investor Relations Partner at DCVC (Data Collective)
Anna Fokina
Investment Director DCVC Bio at DCVC (Data Collective)
Cara Yesko
Associate at DCVC (Data Collective)
Chris Boshuizen
Partner at DCVC (Data Collective)
Christopher Meldrum
Entrepreneur In Residence, DCVC Bio at DCVC Bio
Clay Hutmacher
Operating Partner at DCVC (Data Collective)

Network10

Alan CohenScout
General Partner at DCVC (Data Collective)
Ali TamasebScout
General Partner at DCVC (Data Collective)
Amy SchulmanScout
Managing Partner at Polaris Partners
Anna FokinaScout
Investment Director DCVC Bio at DCVC (Data Collective)
Avidan RossScout
Managing Partner at Root Ventures Manager, Llc
Chris BoshuizenScout
Partner at DCVC (Data Collective)
Chris GibsonScout
Portfolio Director, Private Equity at Bridges Fund Management Ltd.
Dylan ReidScout
Investor at Zetta Venture Partners
Eric Shiozaki, PhDScout
Partner at Revelation Partners
Thiago OlsonScout
Managing Partner at EVE Atlas

Investors connected to James in public investor directories — a warm-intro map.

Frequently asked questions

Who is James Hardiman?
Has invested at DCVC since 2013, focusing on technologies that characterize, model, or manipulate biological systems, robotics and automation, vertical AI applications, and frontier tech like quantum computing. Previously worked on data-driven sales and marketing strategy for life-science and healthcare companies, with experience in healthcare data analysis, materials R&D, and semiconductor processing.
Where does James Hardiman work?
James Hardiman is General Partner at DCVC (Data Collective) and Board director at Noetik and Board director at Shennon Biotechnologies.
What does James Hardiman invest in?
James Hardiman invests in AI & Machine Learning, Biotech, Quantum Computing, Robotics.
What check size does James Hardiman write?
James Hardiman typically writes checks of $5M – $25M.
What boards does James Hardiman sit on?
James Hardiman holds tracked board seats at Noetik, Shennon Biotechnologies.
What companies has James Hardiman invested in?
Investments tracked here include Alta Resource Technologies, Gradle Inc., Lumafield, Noetik, nTop, Nyriad, Q-CTRL, Semantic Health, Sequence Bio, Shennon Biotechnologies, Slip Robotics, Subtle Medical, and 1 more.
Where did James Hardiman go to school?
James Hardiman studied at University of California, Berkeley (BS, Engineering Physics); The University of Chicago Booth School of Business (Master of Business Administration (MBA)).

Same school

Shared employers